MustGrow Biologics Closes $7.1 Million Private Placement
10 October 2021, Canada: MustGrow Biologics Corp. is pleased to announce the closing of its previously-announced non-brokered private placement (the
Read More10 October 2021, Canada: MustGrow Biologics Corp. is pleased to announce the closing of its previously-announced non-brokered private placement (the
Read More29 September 2021, Canada: MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) (“MustGrow”) is pleased to announce it has upsized its
Read More13 September 2021, Canada: MustGrow Biologics Corp. is pleased to announce a non-brokered private placement of approximately 770,000 units for gross
Read More04 August 2021, Canada: MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) (“MustGrow”) and Sumitomo Corporation (TYO: 8053) (OTC: SSUMY) have signed an Exclusive
Read MoreWork completed under non-exclusive agreement with Gowan Group’s biological division Ecoflora Agro in Colombia. MustGrow and Gowan reported control of Fusarium disease in carnation
Read More12 July 2021, Canada: MustGrow Biologics Corp. is pleased to announce successful greenhouse efficacy results of its patented mustard-derived biopesticide on Aphanomyces euteiches zoospores
Read More03 March 2021, Canada: MustGrow Biologics Corp. is pleased to announce that it has isolated and concentrated an additional molecule, thiocyanate,
Read More24 February 2021, Canada: MustGrow Biologics Corp. (the “Company”, “MustGrow”) is pleased to announce receipt of regulatory approval for a powdery
Read More100% control of Fusarium wilt TR4 disease at economic rates as low as 5 gal/acre (49 L/ha). National State of Emergency declared
Read More20 January 2021, Canada: MustGrow Biologics Corp is pleased to announce successful laboratory test results of its patented mustard-derived biopesticide
Read More